Astrana Health Tells SEC Hack Exposed Sensitive Data

Astrana Health notified the SEC of a data breach caused by a social engineering attack, potentially exposing patient, provider, and corporate data. The company is investigating and has taken remedial actions. Astrana, with 2025 revenue of $3.2B, stated the incident is material but does not expect it to affect its financial condition or operations. The company has cyber insurance but cannot guarantee it will cover all losses.

Original reporting
Published Sep 28, 2026, 11:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 12:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefRegulation
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$ASTH
Relevance
6/10
AlphAI data visualization · based on govinfosecurity.com
Decision brief

The 30-second read

Low
01

Why it matters

The filing is the first public disclosure of the incident, making it a primary source of new information for investors.

02

Market read

First‑report of a material cyber breach at a mid‑cap healthcare services firm; may affect stock perception and sector risk assessment.

03

What to watch

Potential regulatory fines and reputational damage could affect partner contracts.

Relevance 6/10Novelty 7/10Timing: today

Background

Astrana Health disclosed a material cyber‑security breach to the SEC, describing the attack, data types potentially exposed, and remediation steps.

Market effects

Highlights cybersecurity risk for healthcare services firms.

May raise scrutiny of US healthcare providers with similar data practices.

Adds to broader concerns about social‑engineering attacks on listed companies.

Counterpoint

The breach may be over‑stated; insurance coverage could limit financial fallout.

Key entities

  • Astrana Health

    California‑based managed services organization in the healthcare sector.

Related articles

$ASTHHighAI 8/10

Astrana Health Earnings Call Highlights Growth and Deleveraging

Astrana Health (ASTH) reported Q3 revenue of $1.02B (+7% YoY) and adjusted EBITDA of $77.2M (+13% YoY). The company highlighted organic growth, debt reduction, and favorable Medicare trends. Management maintained full-year guidance, expecting revenue of $3.9B-$4B and adjusted EBITDA of $261M-$274M. Challenges include Medicaid pressure and seasonality.

$ASTHMed

Astrana Health 3Q 2026: Revenue $1.02B, EPS $0.26 — 10-Q Summary

Astrana Health reported 3Q 2026 revenue of $1.02B, up 7% YoY, and net income of $13.0M, compared to $373K last year. Growth was driven by 9% increase in capitation revenue. Care Partners saw 8% revenue growth and 94% operating income rise, while Care Delivery revenue increased 5% but operating loss widened. Care Enablement revenue rose 5% with 4% higher operating income. Astrana managed 29 IPAs and 1.5M patients as of September 30, 2026.

$ASTHMed

Astrana Health Inc (ASTH) (Q3 2026) Earnings Call Highlights: Record Revenue and EBITDA

Astrana Health Inc (ASTH) reported Q3 2026 earnings, highlighting record revenue and EBITDA growth. CEO Brandon Sim discussed Medicaid membership attrition, Medicare Advantage dynamics, and care enablement business momentum. The company expects mid-teens EBITDA growth despite Medicaid headwinds. A cybersecurity incident is under investigation, and a new 'premiums at risk' disclosure was introduced for ACO business transparency.

$ASTHHighAI 8/10

Astrana Health (ASTH) Q3 2026 Earnings Call Transcript

Astrana Health (ASTH) reported Q3 2026 revenue of $1.02B (+7% YoY) and adjusted EBITDA of $77.2M (+13% YoY). Membership grew to 1.5M, with Medicare Advantage increasing organically. The company completed acquisitions and partnerships, expanding its presence. Medical cost trends were slightly better than expected, with Texas operations performing ahead of plan. Free cash flow reached $105M, and net leverage was reduced to 2.2x.

$ASTHMed

Astrana Health Q3 Earnings Call Highlights

Astrana Health reported 1.5 million members under management, with Medicare Advantage growth offsetting Medicaid attrition. The company expects Medicaid membership to decline 10-15% in 2027, impacting adjusted EBITDA. Medical cost trends were slightly better than expected, with Medicare Advantage margins stable. Astrana plans 82% of capitation revenue from full-risk arrangements by 2026 and completed acquisitions and partnerships.